FDA Cuts Starting Dose of Eszopiclone (Lunesta) in HalfFDA Cuts Starting Dose of Eszopiclone (Lunesta) in Half

The label change stems from new data on the risk for impaired alertness in some people the morning after use of the sleep aid. News Alerts
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news